methylphenidate

(redirected from Methylin)
Also found in: Dictionary, Thesaurus, Wikipedia.

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

methylphenidate

/meth·yl·phen·i·date/ (meth″il-fen´ĭ-dāt) a central stimulant, used in the form of the hydrochloride salt in the treatment of attention-deficit in children and narcolepsy.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.

methylphenidate

a central nervous system stimulant used in the treatment of hyperkinesis and narcolepsy in dogs.
References in periodicals archive ?
All enrolled were given Methylin Oral Solution during the 30-day survey period.
We are excited to have both Methylin Chewable Tablets and Methylin Oral Solution available for physicians to help improve patient compliance," stated Mark Pugh, President and CEO of Alliant.
Alliant voluntarily removed the Methylin Chewable Tablets from the market in February 2005 after its manufacturer, Mallinckrodt, discovered a blending issue in the manufacturing process that could affect dosage potency.
The survey, Methylin Oral Solution in ADHD Patients to Investigate Satisfaction, Convenience and Compliance, or MOSAIC, will evaluate Methylin Oral Solution in up to 10,000 patients at over 500 sites.
We anticipate high marks with regard to satisfaction, convenience and compliance surrounding Methylin Oral Solution.
Methylin Oral Solution was launched in September, 2004 and competes in the ADHD market.
Methylin Chewable Tablet and Methylin Oral Solution were designed specifically to help improve efficacy in treatment.
Methylphenidate, the active ingredient of Methylin, is the leading pharmacotherapy for the treatment of ADHD, with years of proven efficacy and safety.
Mallinckrodt also offers an immediate release formulation of Methylin in 5 mg, 10 mg, and 20 mg tablets.
Methylin ER has an eight-hour duration of action, although behavioral efficacy is assessed most accurately on an individual patient basis.
Methylin ER is an integral part of a total treatment program that typically includes psychological, educational, and social interventions to produce a stabilizing effect in children with ADHD.
The addition of Methylin ER tablets to our product line reflects our commitment to patients with ADHD," said Vince Kaiman, vice president and general manager of the Dosage Products Division of Mallinckrodt's Pharmaceuticals Group.